<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="jns12267-fig-0002" orientation="portrait" position="float">
 <label>Figure 2</label>
 <caption>
  <p>Schedule of study visit assessments during the dose‐evaluation phase. AEs, adverse events; FSS, fatigue severity scale; INCAT, inflammatory neuropathy cause and treatment; I‐RODS, inflammatory Rasch‐built overall disability scale; MRC, Medical Research Council; PGIC, Patients' global impression of change; PI‐NRS, pain intensity numeric rating scale; SF‐36, short form 36 items health status</p>
 </caption>
 <graphic id="nlm-graphic-3" xlink:href="JNS-23-108-g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
